Compounded versus brand GLP-1 products: what the label can and cannot tell you
A practical way to compare approval status, ingredients, presentation, measurement instructions, and accountability without treating a concentration calculation as proof of product equivalence.
Last editorially updated: · By Jeff Schaeffer
Not medical advice. Talk to your prescriber and pharmacist. Confirm your prescribed dose, product, concentration, device, and instructions before using any calculation. This website cannot choose or change your treatment.
Key takeaways
- Compounded drugs are not FDA-approved and are not reviewed the same way before marketing.
- The same mg from two different liquids is an arithmetic match, not proof the products are equivalent.
- A brand name alone does not identify the device, volume, storage limit, or missed-dose rule; read the presentation on the package.
- Ask the dispensing pharmacy and prescriber about your actual product.
Begin with the product's identity
A familiar ingredient name is not a complete description of a medicine. Ask for the exact product name, active ingredient, route, concentration or strength, presentation, dispensing pharmacy, and prescription directions. Branded and compounded products can both have numbers in mg, but those numbers do not answer the same regulatory and quality questions. A carton for an approved product points to product-specific prescribing information and Instructions for Use. A compounded preparation needs its own pharmacy information and individualized prescription context.
This guide does not determine whether a particular compounded prescription is lawful or clinically appropriate. Rules, supply conditions, and enforcement policies can change, and suitability depends on circumstances a website cannot assess. Use the FDA source linked below for current concerns and ask the prescriber and dispensing pharmacy about your actual product. Avoid treating a general educational comparison as a recommendation to buy a medicine from a particular seller, especially when the seller's identity or dispensing arrangement is unclear.
Approval is different from an arithmetic match
FDA-approved products have been reviewed for their labeled safety, effectiveness, and quality. Compounded drugs are not FDA-approved, and FDA does not review them in the same way before marketing. A label stating the same active ingredient name or a similar concentration does not establish equivalent review, manufacturing controls, or clinical outcomes. This distinction remains true even when a calculator produces the same mg from two different liquids. Arithmetic compares stated quantities; it cannot verify what is actually in a vial.
Likewise, a compounded product should not automatically be called a generic equivalent of an approved brand. The word generic has a regulatory meaning beyond containing a named ingredient. Ask what evidence supports any equivalence claim and who is responsible for the preparation. The editorial policy explains why our articles do not turn a units conversion, a referral link, or an anecdote into an endorsement of safety, effectiveness, or approval status.
Brand does not always mean one familiar pen
Older summaries often describe brand products as pens and compounded products as vials. That is too simple for current labeling. The DailyMed labels now include multiple presentations across the brands, including single-dose and multidose formats and, for some semaglutide products, oral formulations under separate instructions. A brand name on its own therefore does not identify the device, administration volume, storage limit, or missed-dose rule. Read the presentation printed on the actual package.
For example, tirzepatide labels distinguish single-dose containers from multidose vials and KwikPens, with different handling details. The Zepbound 50-versus-60-unit explanation shows why vial type matters. Ozempic and Wegovy injection instructions also distinguish among presentations. Do not withdraw medicine from a pen or change a fixed-dose device because a vial calculator appears to offer a cheaper or more flexible way to measure it. Follow the exact Instructions for Use and obtain training when the presentation changes. A device-specific question belongs with the pharmacy or manufacturer.
A compounded vial requires a clear ingredient statement
Ask the pharmacy to identify the active ingredient and any other ingredients separately. A combined preparation can display several numbers, and one ingredient's mg must not be used as another ingredient's concentration. If the label is unclear about whether an amount describes the whole vial, each mL, or a single prescribed administration, have the pharmacy restate it. You should not need to infer the intended concentration from a marketing page or from the total capacity of the glass container.
FDA has raised concerns about unapproved GLP-1 drugs, including products represented with different semaglutide salt forms and dosing errors. The source section links the agency's discussion so readers can distinguish documented regulatory concerns from assumptions. This site does not test ingredients, verify a supplier, or provide a formulation recipe. Do not use it to reconstitute an unidentified powder or to decide that two chemically described products are interchangeable because their names look similar.
Compare measuring workflows, not just milligrams
An approved presentation may deliver a fixed dose or have a labeled dose-selection method. A prescribed vial may require a measured liquid volume using a specified syringe. These workflows have different training needs. If a vial requires conversion, the relevant relationship is prescribed mg divided by verified mg/mL equals mL. U-100 units are then mL multiplied by 100 only when a U-100 syringe is the intended device. A correct formula cannot replace confirmation of that device choice.
In a hypothetical example, 0.5 mg at 2.5 mg/mL occupies 0.2 mL, while the same mg at 5 mg/mL occupies 0.1 mL. Neither concentration is recommended by this example. It simply shows why a pharmacy change can alter the syringe number without changing the prescribed medicine amount. Ask for a written read-back of mg, concentration, mL, and device markings. The syringe guide explains the scale once those product facts are settled.
Storage and beyond-use dates are not interchangeable
An approved product's storage instructions are specific to its formulation and presentation. A multidose pen's in-use limit cannot be copied onto a compounded vial, and one brand's room-temperature allowance cannot be transferred to another product because both contain a GLP-1 medicine. Ask the dispensing pharmacy for the compounded preparation's beyond-use date, the conditions needed to maintain it, and the instructions after the first puncture. Keep those directions with the container.
If a shipment was delayed, frozen, or exposed to heat, report the circumstances to the pharmacy before use. The amount remaining in the vial does not establish usability. Nor does a clear appearance prove that every storage condition was met. For a useful call, provide the exact product, presentation, relevant dates, approximate temperature history, and whether it has been opened. The storage and travel guide turns those details into a practical checklist without inventing a universal deadline.
Missed-dose rules belong to the actual prescription
The FDA labels for approved weekly injections contain product-specific timing rules. They are not universal rules for every compounded preparation containing the same ingredient. Ask the prescriber to provide written instructions for a missed dose, an uncertain administration, and a longer treatment interruption. Avoid adopting an online statement that most clinics use a particular brand's rule; that is not a substitute for instructions for your prescription. This site does not supply an unsupported compounded restart schedule.
For approved products, our label comparison identifies the differing reference points and timing windows. If you switch products, update the written plan rather than keeping the old missed-dose rule from memory. If you have already administered an uncertain amount, ask a healthcare professional promptly. The ability to calculate the amount does not determine whether it was safe or what follow-up is needed.
Financial comparisons need equal definitions
Compare the net cost of the actual prescribed product and services, not two unrelated advertised monthly numbers. One plan may quote a four-week supply while another quotes calendar-month membership. Visits, labs, shipping, supplies, and changes in prescribed amount can alter the total. Obtain a written quote and ask what is included. A low price cannot resolve questions about approval, ingredient identity, device training, or appropriate care, and a higher price does not itself prove those qualities either.
Use the cost calculator to make the billing assumptions visible after clinical suitability has been discussed. It does not rank pharmacies, verify savings eligibility, or choose a provider. If you cannot identify the dispensing pharmacy, get understandable directions, or obtain an answer about the product's ingredients, address those gaps before relying on a financial comparison. Missing information is a reason to seek clarification, not to fill in a favorable assumption.
Questions that make a prescriber or pharmacy call useful
Ask who prepares and dispenses the product, what exact ingredient and presentation are prescribed, how the stated concentration is confirmed, and what written instructions cover measuring, storage, missed doses, and adverse-event concerns. Request training for the actual device rather than a generic video. If the product differs from an approved presentation because of a patient-specific need, ask the prescriber to explain that reasoning in terms you understand. The site cannot make that determination for you.
Keep the responses and a copy of the current label together. Revisit them when a refill changes concentration, presentation, or pharmacy. This approach avoids relying on a broad brand-versus-compounded slogan when the real question is about a specific prescription. The goal is an identifiable product, understandable instructions, and a professional contact who can resolve discrepancies. No calculator result can supply those missing parts of care.
Comparing GLP-1 program costs?
Use your actual provider quote to estimate the full cost with our cost calculator. You can also review pricing and eligibility directly with a telehealth provider.
SkinnyRxOral and injectable GLP-1 options, with financing.See SkinnyRx options →Disclosure: GLP1 Math may earn a commission if you sign up through these links. It costs you nothing extra and does not change what the calculators show. A provider listing is not a medical recommendation.
Frequently asked questions
Is compounded semaglutide an FDA-approved generic?
Do not assume that. Compounded preparations are not FDA-approved, and matching an ingredient name or calculated mg does not establish approved generic equivalence. Consult FDA information and ask the prescriber and pharmacy about the exact preparation.
Are all branded GLP-1 medicines supplied as pens?
No. Current labels include several presentations, and some semaglutide products have oral formulations with separate instructions. Identify the exact package and device. Older summaries that equate brand with pen and compounded with vial are incomplete.
Can a calculator prove two products are equivalent?
No. It can compare stated amounts and volumes, but it cannot verify ingredients, potency, quality, sterility, regulatory status, or clinical outcomes. Those questions require appropriate professional and regulatory sources.
Can I borrow a brand storage deadline for a compounded vial?
No. Obtain the dispensing pharmacy’s product-specific beyond-use and after-puncture instructions. A brand’s device-specific storage limit is not evidence for a different preparation, even when an ingredient name is shared.
What should change after switching pharmacies?
Reconfirm ingredient, concentration, prescribed mg, volume, device, storage instructions, and contact details. A syringe number from the previous fill may represent a different medicine amount in the new product. Ask for written instructions and appropriate training.
Does a referral link mean the site recommends a prescription?
No. Any commercial relationship should be disclosed, but it cannot establish clinical suitability or regulatory approval. Discuss product choices with your prescriber and verify dispensing and billing details directly with the provider.
Sources
- FDA concerns about unapproved GLP-1 drugs used for weight loss
- FDA: dosing errors associated with compounded injectable semaglutide
- Wegovy prescribing information: injection and tablet sections are separate
- Ozempic injection prescribing information
- Zepbound prescribing information
- Mounjaro prescribing information